To the full analysis
MiniMed Group stock: growth
MMEDMiniMed Group reported $3.1B in revenue for fiscal 2025, up 14.3% on the prior year, up 11.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
11.4%
per year from 2022 to 2025, per share 14.8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2022 | |
|---|---|
| Revenue | 11.4% |
| Revenue per share | 14.8% |
| Earnings | no data |
| Earnings per share | no data |
| Free cash flow | no data |
| Free cash flow per share | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2022 | $2.25B | −$96M | −$173M |
| 2023 | $2.47B | −$112M | −$107M |
| 2024 | $2.72B | −$250M | −$53M |
| 2025 | $3.1B | −$331M | −$420M |
Revenue by region
Where MiniMed Group, Inc. generates its revenue.
- Outside the US$2.2B70%
- United States$917.0M30%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Outside the US | $2.19B | 70.4% |
| United States | $917M | 29.6% |
| Total revenue | $3.1B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 24 Apr 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 15 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.